Homology: Q32 Bio concludes merger deal with Homology Medicines

With the deal closing, the merged business will now function under the name Q32 Bio. Concurrent with the merger's closure, Q32 Bio also finalised a $42m private placement. The post Q32 Bio concludes merger deal with Homology Medicines appeared first on Pharmaceutical Business review.